Pertinencia y riesgo de las aplicaciones nucleares
Resumen
Referencias
SHARKEY RM, GOLDENBERG DM. Perspectives on Cancer Therapy with Radiolabeled Monoclonal Antibodies. J. Nucl. Med. 2005;(46):115S-127S.
BRITTON KE. The J-shaped response to radiation. World J. Nucl. Med. 2004;(3):115-118.
KESSLER G. Requirements for nuclear energy in the 21st century. Nuclear energy as a sustainable energy source. Progress in Nuclear Energy. 2002;40(3-4):309-325.
KLAPISH R. Accelerator driven systems: an application of proton accelerators to nuclear power industry. Europhysics News. 2000;31(6).
LUCIGNANI G, JERECZEK-FOSSA BA, ORECCHIA R. The role of molecular imaging in precision radiation therapy for target definition, treatment planning optimisation and quality control. Eur J Nucl Med Mol Imaging. 2004;(31):1059-1063.
MAN-SUNG, YIM; VAGANOV, P.A. Effect of education in nuclear risk perception and attitude: theory. Progress in Nuclear Energy. 2003;42(2):221-235.
WALTERS LC, PORTER DL, CRAWFORD DC. Nuclear fuel considerations for the 21st century. Progress in Nuclear Energy. 2002;40(3-4):513-521.
